1. Lempainen, Johanna, Korhonen, Laura S, Kantojärvi, Katri, Paunio, Tiina, Peltola, Ville. . Associations Between IFI44L Gene Variants and Rates of Respiratory Tract Infections During Early Childhood. In The Journal of infectious diseases, 223, 157-165. doi:10.1093/infdis/jiaa341. https://pubmed.ncbi.nlm.nih.gov/32561935/
2. Salesi, Mansour, Dehabadi, Milad Hayeri, Salehi, Rasoul, Salehi, Amirhossein, Pakzad, Bahram. 2022. Differentially methylation of IFI44L gene promoter in Iranian patients with systemic lupus erythematosus and rheumatoid arthritis. In Molecular biology reports, 49, 3065-3072. doi:10.1007/s11033-022-07134-5. https://pubmed.ncbi.nlm.nih.gov/35059970/
3. Zhao, Xingwang, Zhang, Longlong, Wang, Juan, Ni, Bing, You, Yi. 2021. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. In Journal of translational medicine, 19, 35. doi:10.1186/s12967-020-02698-x. https://pubmed.ncbi.nlm.nih.gov/33468161/
4. Li, Yutong, Zhang, Junshi, Wang, Chenchen, Li, Yue, Tan, Juan. 2020. IFI44L expression is regulated by IRF-1 and HIV-1. In FEBS open bio, 11, 105-113. doi:10.1002/2211-5463.13030. https://pubmed.ncbi.nlm.nih.gov/33159419/
5. Zeng, Yong, Chen, Hong-Qiang, Zhang, Zhe, Zhou, Zi-Yuan, Liu, Wen-Bin. 2022. IFI44L as a novel epigenetic silencing tumor suppressor promotes apoptosis through JAK/STAT1 pathway during lung carcinogenesis. In Environmental pollution (Barking, Essex : 1987), 319, 120943. doi:10.1016/j.envpol.2022.120943. https://pubmed.ncbi.nlm.nih.gov/36584854/